Usted buscó: international normalized ratio (Inglés - Maltés)

international normalized ratio (inr) in subjects treated with warfarin.
jingħataw parir sabiex jevitaw ix- xorb alkoħoliku waqt li jkunu qegħdin jieħdu mirtazapine.

it is recommended that the inr (international normalized ratio) be monitored.
huwa rakkomandat li l-inr (proporzjon normalizzat internazzjonali) jiġi ssorveljat.

dabigatran etexilate can be given as soon as the international normalized ratio (inr) is < 2.0.
dabigatran etexilate jista’ jingħata hekk kif il-proporzjon normalizzat internazzjonali (international normalized ratio-inr) ikun ta’ < 2.0.

common: increased bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, increased international normalized ratio
komuni: Żieda fil-bilirubina, Żieda f’alanine aminotransferase, Żieda fl-aspartate aminotransferase, Żieda fil-proporzjon normalizzat internazzjonali

in addition, albiglutide did not significantly alter the pharmacodynamic effects of warfarin as measured by the international normalized ratio.
barra minn hekk, albiglutide ma biddilx b’mod sinifikanti l-effetti farmakodinamiċi ta’ warfarin kif imkejla permezz tal-proporzjon normalizzat internazzjonali.

increase in other laboratory measurements (increased international normalized ratio) related to the blood clotting system function
Żieda f’kejl ieħor tal-laboratorju (żieda fil-proporzjon normalizzat internazzjonali) relatat mal- funzjoni tas-sistema tat-tagħqid tad-demm

it is recommended that the international normalized ratio (inr) be monitored carefully during treatment with viracept, especially when commencing therapy.
huwa rrakkomandat li l-proporzjon normalizzat internazzjonali (inr) jiġi mmonitorjat b’attenzjoni waqt il- kura b’viracept, speċjalment fil-bidu tat-terapija.

in post marketing experience isolated cases with international normalized ratio (inr) increases have been reported in patients concomitantly treated with warfarin.
fl- esperjenza wara t- tqegħid fis- suq, każijiet iżolati b’ żidiet fil- proporzjon internazzjonali normalizzat (inr) kienu rrappurtati f’ pazjenti li kienu qed jingħataw fl- istess waqt warfarin.

multiple dose administration of 200 mg thalidomide q.d. for 4 days had no effect on the international normalized ratio (inr) in healthy volunteers.
l-għoti ta’ doża multipla ta’ 200 mg thalidomide q.d. għal 4 t’ijiem ma kelliex effett fuq il-proporzjon intenazzjonali normalizzat (inr – international normalized ratio) fuq voluntieri b’saħħithom.

however, since market introduction, increased inr (international normalized ratio) has been reported spontaneously during concomitant use of warfarin and exenatide.
madanakollu, mill-introduzzjoni fis-suq, ġiet irrapportata żieda fl-inr b’mod spontanju waqt l-użu ta’ warfarin u exenatide fl-istess waqt.

high levels of certain enzymes involved in digestion (increase in amylase and lipase) abnormal blood clotting condition (abnormal international normalized ratio).
livelli għolja ta’ ċertu enzimi involuti fil-diġestjoni (żieda f’amylase u lipase) kondizzjoni fejn id-demm ma jagħqadx b’mod normali (proporzjon normalizzat internazzjonali mhux normali)

the readout for pt is to be done in seconds, because the inr (international normalized ratio) is only calibrated and validated for coumarins and cannot be used for any other anticoagulant.
il- qari tar- riżultat għal pt għandha ssir fi ftit sekondi, għax l- inr (proporzjon normalizzat

patients taking concomitant anticoagulation, such as warfarin or phenprocoumon should be monitored regularly for changes in prothrombin time, international normalized ratio (inr), and clinical bleeding episodes.
pazjenti li jkunu qed jieħdu mediċina antikoagulanti fl-istess ħin, bħal warfarin jew phenprocoumon, għandhom jiġu mmonitorjati regolarment għal tibdil fil-ħin tal-prothrombin, il-proporzjon normalizzat internazzjonali (inr), u episodji kliniċi ta' ħruġ ta' demm.

in addition, in patients, ambrisentan had no overall effect on the weekly warfarin-type anticoagulant dose, prothrombin time (pt) and international normalized ratio (inr).
barra minn hekk, fil- pazjenti, ambrisentan ma kellu l- ebda effett fuq kollox fuq id- doża ta 'warfarin tat- tip li tingħata kull ġimgħa, il- prothrombin time (pt) u l- international normalized ratio (inr).

caution should be exercised and additional international normalized ratio (inr) monitoring is recommended when dabrafenib is used concomitantly with warfarin and at discontinuation of dabrafenib (see section 4.5).
għandha tiġi eżerċitata kawtela u huwa rakkomandat li jsir monitoraġġ addizzjonali tal-proporzjon normalizzat internazzjonali (inr) meta dabrafenib jintuża flimkien ma’ warfarin u wara waqfien ta’ dabrafenib (ara sezzjoni 4.5).

anaemia, leucopenia, neutropenia, thrombocytopenia, prothrombin time (pt) prolonged, activated partial thromboplastin time (aptt) prolonged, international normalized ratio (inr) increased
anemija, lewkopenija, newtropenija, tromboċitopen ja, ħin tal- protrombin imtawwal (pt), titwil fil-ħin ta’ tromboplastin parzjali attivat (aptt), Żieda fil-proporzjon internazzjonal i normalizzat (inr)

interaction with coumarin-derived anticoagulants including warfarin leading to increased international normalized ratio (inr) and bleeding events, which in some cases were fatal, have been reported in patients receiving tarceva.
f’pazjenti li jirċievu tarceva, kienet irrappurtata interazzjoni ma’ sustanzi kontra t-tagħqid tad-demm derivati minn coumarin, inkluż warfarin, li wasslet għall-żjieda fl-international normalized ratio (inr) u episodji ta’ fsada li f’xi każijiet kienu fatali.

mean international normalized ratio (inr) auc and maximum value of inr after single-dose warfarin administration with lasofoxifene were approximately 8% and 16% lower, respectively, than after warfarin alone.
il-medja tal- proporzjon normalizzat internazzjonali (inr) tal-auc u l-valur massimu tal-inr wara li ngħatat doża waħda ta’ warfarin flimkien ma’ lasofoxifene, kienu ta’ bejn wieħed u ieħor 8% u 16% inqas, rispettivament, milli kienu wara li ngħata warfarin waħdu.

clinical experience with concomitant administration of bosentan with warfarin in patients with pulmonary arterial hypertension did not result in clinically relevant changes in international normalized ratio (inr) or warfarin dose (baseline versus end of the clinical studies).
l-esperjenza klinika bl-għoti ta’ bosentan flimkien ma’ warfarin f’pazjenti bi pressjoni għolja arterjali pulmonari ma rriżultatx f’bidliet kliniċi rilevanti tal-proporzjon normalizzat internazzjonali (inr) jew tad-doża ta’ warfarin (linja bażi meta mqabbla mal-livelli li ntlaħqu fit-tmiem ta’ l-istudji kliniċi).

although cases of hepatic dysfunction (elevated aminotransferase with increase in bilirubin or international normalized ratio [inr]) or hepatic failure have not been reported, there is concern that lomitapide could induce steatohepatitis, which can progress to cirrhosis over several years.
għalkemm ma ġewx irrapportati każijiet ta’ disfunzjoni epatika (żidiet fl-aminotransferażi b’żieda fil-bilirubin jew fil-proporzjon normalizzat internazzjonali [inr]) jew insuffiċjenza epatika, hemm tħassib li lomitapide jista’ jinduċi steatohepatitis, li tista’ tavvanza għal ċirrożi wara diversi snin.